Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05032820
Title MM CAR-T to Upgrade Response
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Marcelo Pasquini, MD

multiple myeloma


Cyclophosphamide + Fludarabine

Idecabtagene Vicleucel + Lenalidomide

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.